ELAINE NGO: Open Payments
NPI 1285390153 · NEWARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,478 in 91 payments from 17 companies in 2025. Trend: 2023 $344 · 2024 $1,691 · 2025 $2,478
Food & beverage: $2,393Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $776 |
| Janssen Biotech, Inc. | 17 | $419 |
| Gilead Sciences, Inc. | 16 | $413 |
| Ardelyx, Inc. | 1 | $128 |
| Celltrion USA Inc. | 6 | $121 |
| GENZYME CORPORATION | 6 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Ipsen Biopharmaceuticals, Inc | 4 | $90 |
| Intra-Sana Laboratories | 1 | $50 |
| Novo Nordisk Inc | 3 | $47 |
Products named: TREMFYA, SKYRIZI, RINVOQ, IBSRELA, VEGZELMA, DUPIXENT, CREON, XIFAXAN.
Industry payments across CA — which companies pay providers there.
